Cubist Systematic Strategies’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Cubist Systematic Strategies’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,471	Closed	-$257K	–	4736
2022 Q3	$257K	Buy	25,471 +2,141	+9%	+$21.6K	﹤0.01%	3604
2022 Q2	$235K	Buy	+23,330	New	+$235K	﹤0.01%	3601

Other funds holding PBAXU

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Cubist Systematic Strategies's PBAXU Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 25,471 shares — an estimated $257K sold.

Cubist Systematic Strategies first reported a position in PBAXU in Q2 2022 and held it in 2 quarters. The position peaked at $257K in Q3 2022. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.

Cubist Systematic Strategies reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 25,471 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $257K.
Cubist Systematic Strategies first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q2 2022 and held it in 2 quarters.
Cubist Systematic Strategies's Phoenix Biotech Acquisition Corp. Unit position peaked at $257K in Q3 2022.
3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.